Nabla Bio

AI Platform Engineer

Reposted 11 Days Ago

Boston, MA, USA

In-Office

Senior level

Artificial Intelligence • Software • Biotech

The Role

The AI Platform Engineer will develop full-stack systems connecting AI models to real-world applications in drug design, collaborating with scientists and ensuring rapid experimentation cycles.

Summary Generated by Built In

Nabla Bio is building AI to design new medicines. We combine cutting-edge ML with fast, human-relevant lab validation to create biomolecules on demand. This lets us go after hard diseases and build new drug formats that traditional approaches can’t reach. We’re backed by top investors like Radical and Khosla Ventures and have forged significant partnerships with leading pharma companies.

The Role

We’re hiring a senior engineer to build core infrastructure and tools that connect our AI models to real-world use. You’ll work across the full stack — front-end, back-end, and ML infrastructure — to build systems that close the gap between idea and implementation for our AI and wet-lab scientists. Your work will enable faster design cycles, tighter feedback loops, and more seamless collaboration across disciplines.

This is a high-impact, hands-on role that directly supports our scientists, collaborators, and pharma partners. You’ll build APIs, dashboards, training and inference pipelines that turn frontier AI models into production-grade tools for drug design. Another focus will be accelerating scientific workflows with LLMs — building systems where AI helps propose and learn from experiments to drive faster cycles of discovery. It’s a rare opportunity to engineer this loop with real-world, large-scale experimental feedback (1 million drug designs measured every month). See our papers for examples of our work [1][2], and their coverage in Science Magazine and Endpoints News.

This is an in-person role in Cambridge, MA. You will:

Build and maintain user-facing applications (UIs, APIs, and dashboards) that reduce the idea-to-implementation gap in drug design workflows
Develop robust ML training and inference systems to accelerate experimentation during model development and expose our models through scalable back-end services
Collaborate closely with scientists to understand pain points and ship high-leverage tools, including AI-augmented experiment planning and analysis
Own full-stack development from prototype to production, including deployment and observability
Leverage modern AI dev tooling to move fast and stay focused on high-value work

Qualifications

5+ years of experience as a full-stack, ML infra, or platform engineer
Experience building backend systems that serve ML models in production
Strong frontend development skills (React, TypeScript, etc.)
Deep fluency in Python; familiarity with cloud-native tools and containerization (Kubernetes, Docker)
Strong product taste, sense, and ability to partner with wet-lab scientists and AI researchers
High agency and a track record of shipping quickly with quality

What We Offer

A fast-moving environment where you can build and ship tools that impact real drug programs
The opportunity to shape how cutting-edge AI and LLMs are used to accelerate scientific discovery
Access to modern ML models and wet-lab infrastructure for rapid experimentation
A small, focused team where your engineering decisions have outsized impact
Highly competitive salary, equity, and benefits package

Nabla Bio is an equal opportunity employer. We welcome applicants from all backgrounds and experiences, and strongly encourage candidates from underrepresented groups in science and technology to apply.

View all jobs at Nabla Bio

View Nabla Bio Profile

Report Job

Am I A Good Fit?

beta

Get Personalized Job Insights.

Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company

HQ: Cambridge, Massachusetts

22 Employees

What We Do

We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets. To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates. If successful we could double the number of disease-relevant drug targets the industry advances for drug development. Since launching in 2021 we have raised $37 million with the backing of leading investors, including Radical Ventures, Khosla Ventures and Zetta Venture Partners. Our technical team is based in Cambridge, Massachusetts and continues to recruit top machine learning and synthetic biology talent. For more information check out the Careers section of our website at www.nabla.bio.